Companies / Ligand Pharmaceuticals Inc / Activity
Activity — Ligand Pharmaceuticals Inc
110 moves.
Top impactInsider · CEO movesInsider · biggest buysInsider · biggest sellsInstitution · biggest movesInstitution · new positions
| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Jun 5, 2026 | Aryeh Jason Director | Grant | Common Stock | $0 | +836 +0.78% | 107,580 0.54% of shares | low |
| Jun 5, 2026 | Kozarich John W Director | Grant | Common Stock | $0 | +836 +2.00% | 42,622 0.21% of shares | low |
| Jun 5, 2026 | Lamattina John L Director | Grant | Common Stock | $0 | +836 +2.72% | 31,560 0.16% of shares | low |
| Feb 14, 2026 | Reardon Andrew Executive | Grant | Common Stock | $0 | +9K +25.52% | 43,338 0.22% of shares | low |
| Feb 14, 2026 | Reardon Andrew Executive | Grant | Common Stock | $0 | +7K +22.49% | 37,739 0.19% of shares | low |
| Feb 14, 2026 | Espinoza Octavio Executive | Grant | Common Stock | $0 | +9K +27.36% | 41,014 0.21% of shares | low |
| Feb 14, 2026 | Espinoza Octavio Executive | Grant | Common Stock | $0 | +7K +25.86% | 35,965 0.18% of shares | low |
| Mar 2, 2026 | Espinoza Octavio Executive | Grant | Common Stock | $0 | +5K +14.94% | 37,945 0.19% of shares | low |
| Mar 2, 2026 | Davis Todd C CEO | Grant | Common Stock | $0 | +10K +5.56% | 199,381 1.00% of shares | low |
| Mar 2, 2026 | Reardon Andrew Executive | Grant | Common Stock | $0 | +5K +12.24% | 41,382 0.21% of shares | low |
| Feb 14, 2026 | Davis Todd C CEO | Grant | Common Stock | $0 | +40K +22.79% | 213,585 1.07% of shares | low |
| Feb 14, 2026 | Davis Todd C CEO | Grant | Common Stock | $0 | +21K +12.88% | 182,119 0.91% of shares | low |
| Feb 2, 2026 | Kozarich John W Director | Sell | Common Stock | $192 | -1 -0.00% | 43,614 0.22% of shares | low |
| May 1, 2026 | Kozarich John W Director | Sell | Common Stock | $230 | -1 -0.00% | 42,172 0.21% of shares | low |
| Dec 31, 2025 | Espinoza Octavio Executive | Other | Common Stock | $765 | +8 +0.03% | 28,575 0.14% of shares | low |
| Jan 2, 2026 | Kozarich John W Director | Sell | Common Stock | $3.9K | -21 -0.05% | 44,100 0.22% of shares | low |
| Feb 2, 2026 | Kozarich John W Director | Sell | Common Stock | $4.5K | -23 -0.05% | 43,591 0.22% of shares | low |
| Feb 2, 2026 | Kozarich John W Director | Sell | Common Stock | $4.5K | -23 -0.05% | 43,187 0.22% of shares | low |
| Feb 2, 2026 | Kozarich John W Director | Sell | Common Stock | $7.4K | -39 -0.09% | 43,615 0.22% of shares | low |
| Apr 1, 2026 | Kozarich John W Director | Sell | Common Stock | $8.0K | -40 -0.09% | 42,534 0.21% of shares | low |
| Mar 2, 2026 | Kozarich John W Director | Sell | Common Stock | $8.2K | -41 -0.10% | 42,895 0.22% of shares | low |
| Mar 2, 2026 | Kozarich John W Director | Sell | Common Stock | $8.5K | -42 -0.10% | 42,720 0.21% of shares | low |
| Apr 1, 2026 | Kozarich John W Director | Sell | Common Stock | $8.7K | -43 -0.10% | 42,412 0.21% of shares | low |
| Jan 2, 2026 | Kozarich John W Director | Sell | Common Stock | $8.9K | -46 -0.11% | 43,654 0.22% of shares | low |
| Mar 2, 2026 | Kozarich John W Director | Sell | Common Stock | $9.3K | -47 -0.11% | 43,140 0.22% of shares | low |
| Mar 2, 2026 | Kozarich John W Director | Sell | Common Stock | $10.1K | -50 -0.12% | 42,762 0.21% of shares | low |
| Mar 4, 2026 | Espinoza Octavio Executive | Sell | Common Stock | $10.6K | -53 -0.15% | 34,333 0.17% of shares | low |
| Apr 1, 2026 | Kozarich John W Director | Sell | Common Stock | $16.0K | -79 -0.19% | 42,455 0.21% of shares | low |
| Mar 2, 2026 | Kozarich John W Director | Sell | Common Stock | $16.7K | -83 -0.19% | 42,812 0.21% of shares | low |
| Jan 2, 2026 | Kozarich John W Director | Sell | Common Stock | $17.1K | -91 -0.21% | 44,009 0.22% of shares | low |
| May 1, 2026 | Kozarich John W Director | Sell | Common Stock | $18.2K | -80 -0.19% | 42,173 0.21% of shares | low |
| Mar 4, 2026 | Reardon Andrew Executive | Sell | Common Stock | $18.7K | -93 -0.22% | 41,369 0.21% of shares | low |
| Jan 2, 2026 | Kozarich John W Director | Sell | Common Stock | $19.3K | -102 -0.23% | 43,907 0.22% of shares | low |
| Mar 4, 2026 | Reardon Andrew Executive | Sell | Common Stock | $19.8K | -100 -0.24% | 41,769 0.21% of shares | low |
| Mar 4, 2026 | Reardon Andrew Executive | Sell | Common Stock | $19.9K | -100 -0.24% | 41,669 0.21% of shares | low |
| May 1, 2026 | Kozarich John W Director | Sell | Common Stock | $24.4K | -105 -0.25% | 41,902 0.21% of shares | low |
| May 1, 2026 | Kozarich John W Director | Sell | Common Stock | $27.2K | -116 -0.28% | 41,786 0.21% of shares | low |
| Apr 1, 2026 | Kozarich John W Director | Sell | Common Stock | $29.2K | -146 -0.34% | 42,574 0.21% of shares | low |
| May 12, 2026 | Kozarich John W Director | Exercise | Common Stock | $31.9K | +459 +1.10% | 42,245 0.21% of shares | low |
| Apr 1, 2026 | Kozarich John W Director | Sell | Common Stock | $32.5K | -159 -0.37% | 42,253 0.21% of shares | low |
| Mar 4, 2026 | Espinoza Octavio Executive | Exercise | Common Stock | $37.6K | +466 +1.35% | 35,085 0.18% of shares | low |
| May 1, 2026 | Kozarich John W Director | Sell | Common Stock | $38.3K | -165 -0.39% | 42,007 0.21% of shares | low |
| Jan 2, 2026 | Kozarich John W Director | Sell | Common Stock | $39.4K | -207 -0.47% | 43,700 0.22% of shares | low |
| Mar 2, 2026 | Kozarich John W Director | Sell | Common Stock | $40.7K | -204 -0.47% | 42,936 0.22% of shares | low |
| Mar 4, 2026 | Reardon Andrew Executive | Sell | Common Stock | $40.8K | -200 -0.49% | 40,869 0.21% of shares | low |
| Mar 4, 2026 | Reardon Andrew Executive | Sell | Common Stock | $41.4K | -207 -0.50% | 41,462 0.21% of shares | low |
| Jun 10, 2026 | Lamattina John L Director | Sell | Common Stock | $57.6K | -232 -0.74% | 31,071 0.16% of shares | low |
| Mar 4, 2026 | Reardon Andrew Executive | Sell | Common Stock | $60.5K | -300 -0.73% | 41,069 0.21% of shares | low |
| Jun 10, 2026 | Lamattina John L Director | Sell | Common Stock | $63.5K | -257 -0.81% | 31,303 0.16% of shares | low |
| Mar 4, 2026 | Reardon Andrew Executive | Sell | Common Stock | $70.2K | -340 -0.84% | 40,069 0.20% of shares | low |